CAMBRIDGE, Mass., June 11, 2020 /PRNewswire/ -- Leap Therapeutics,
Inc. (Nasdaq: LPTX), a biotechnology company focused on developing
targeted and immuno-oncology therapeutics, today announced that,
due to public health and safety concerns related to the outbreak of
the novel coronavirus ("COVID-19"), and to support the health and
well-being of its stockholders, employees and others, the Company
is changing its 2020 Annual Meeting of Stockholders (the "Annual
Meeting") to a virtual-only format. The virtual Annual Meeting is
expected to provide stockholders with the same rights and
opportunities to participate as they would have had at an in-person
meeting. Stockholders can submit questions related to the matters
to be voted on at the virtual Annual Meeting by using the
instructions on the virtual meeting website listed below.
In order to accommodate a virtual-only meeting format, the
Annual Meeting will now be held at 4:00
p.m., eastern time, on Tuesday, June
16, 2020. Online access to the Annual Meeting will begin at
3:45 p.m., eastern time. Stockholders
will not be able to attend the Annual Meeting in person.
Attending the Virtual Meeting as a Stockholder of
Record
The Company's stockholders of record as of April 24, 2020 (the "Record Date") can attend the
Annual Meeting by accessing
https://www.cstproxy.com/leaptx/2020 and entering the
control number on the proxy card previously received. Instructions
on how to access the Annual Meeting and participate via the
Internet, including how to demonstrate proof of stock ownership,
and voting instructions, can be found at
https://www.cstproxy.com/leaptx/2020.
Attending the Virtual Meeting as a Beneficial Owner
Beneficial stockholders as of the Record Date (i.e. shares held
in "street name" through an intermediary, such as a bank or broker)
who want to be able to attend the Annual Meeting can attend using
the control number found on the notice and instructions received
from their broker or other nominee.
Attending the Virtual Meeting as a Guest
Guests may participate in a listen-only mode. No control number
is required.
Stockholders who do not have their control number will be able
to access the virtual Annual Meeting as guests but will not be able
to vote their shares or submit questions during the Annual
Meeting.
Voting Shares
Stockholders of record and beneficial owners will be able to
vote their shares electronically during the virtual Annual Meeting
by using the control number. Instructions on how to vote while
participating in the Annual Meeting live via the Internet are
posted at https://www.cstproxy.com/leaptx/2020.
Whether or not stockholders plan to virtually attend the Annual
Meeting, the Company urges them to vote by one of the methods
described in the proxy materials for the Annual Meeting.
The proxy materials that were distributed along with the
definitive proxy statement will not be updated to reflect the
virtual-only format of the Annual Meeting.
List of Stockholders
A list of stockholders entitled to vote at the Annual Meeting
and instructions for accessing the stockholder list will also be
available during the Annual Meeting at
https://www.cstproxy.com/leaptx/2020.
About Leap Therapeutics
Leap Therapeutics (Nasdaq:LPTX) is focused on developing
targeted and immuno-oncology therapeutics. Leap's most advanced
clinical candidate, DKN-01, is a humanized monoclonal antibody
targeting the Dickkopf-1 (DKK1)
protein, a Wnt pathway modulator. DKN-01 is in clinical trials in
patients with esophagogastric, hepatobiliary, gynecologic, and
prostate cancers. Leap has formed a partnership with BeiGene, Ltd.
for the rights to develop DKN-01 in Asia (excluding Japan), Australia, and New
Zealand. For more information about Leap Therapeutics,
visit http://www.leaptx.com or view our public filings
with the SEC that are available via EDGAR
at http://www.sec.gov or
via https://investors.leaptx.com/.
Contact:
Douglas E. Onsi
President & Chief Executive Officer
Leap Therapeutics, Inc.
617-714-0360
donsi@leaptx.com
Heather Savelle
Investor Relations
Argot Partners
212-600-1902
heather@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/leap-therapeutics-announces-changes-to-virtual-format-and-time-for-2020-annual-meeting-of-stockholders-301074687.html
SOURCE Leap Therapeutics, Inc.